-
Loading metrics
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study
- Francesco Patti,
- Vincenzo Brescia Morra,
- Maria Pia Amato,
- Maria Trojano,
- Stefano Bastianello,
- Maria Rosalia Tola,
- Salvatore Cottone,
- Andrea Plant,
- Orietta Picconi
x
- Published: August 30, 2013
- https://doi.org/10.1371/journal.pone.0074111